ARDX logo

Ardelyx, Inc. (ARDX)

Profile

Full Name

Ardelyx, Inc.

Ticker

NASDAQ: ARDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 19, 2014

Indexes

Not included

Website

https://www.ardelyx.com

Employees

395

Key Details

Price

$5.36(-2.72%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$333.62M(168.06% YoY)

Annual EPS

-$0.17(44.75% YoY)

PE Ratio

-

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.36
    ARDX price is $5.36

    30-Day Relative Volume

    0.94
    ARDX 30-day relative volume is 0.94

    Price Performance

    Price Most Recent Change

    -2.72%
    ARDX price was down -2.72% on Oct 1, 2025

    Price YTD Change

    +5.72%
    ARDX price is up +5.72% since January 1st

    Price 1-Year Change

    -22.66%
    ARDX price is down -22.66% year-on-year

    Price 3-Year Change

    +350.42%
    ARDX price is up +350.42% over the past 3 years

    Price Range

    Price All-Time High

    $35.48
    ARDX price is currently -84.89% below its historical high of $35.48

    Price 3-Year Low

    $1.16
    ARDX price is currently +362.07% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.29B
    ARDX market cap is $1.29 billion

    Market Cap 3-Year Change

    +479.21%
    ARDX market cap is up +479.21% over the past 3 years

    Market Cap All-Time High

    $2.26B
    ARDX market cap is currently -42.95% below its historical high of $2.26 billion

    Market Cap Sector Percentile

    75.11%
    ARDX market cap is higher than 75.11% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.73%
    ARDX shares outstanding is up +1.73% year-on-year

    Shares Outstanding 3-Year Change

    +28.59%
    ARDX shares outstanding is up +28.59% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    ARDX beta is 0.66

    200-day SMA

    $4.98
    ARDX price is currently +7.73% above its 200-day simple moving average

    50-day SMA

    $5.73
    ARDX price is currently -6.46% below its 50-day simple moving average

    14-Day RSI

    30.97
    ARDX 14-day relative strength index is 30.97

    Volume

    0.94
    ARDX 30-day relative volume is 0.94

    ATR

    $0.22
    ARDX average true range is $0.22

    10-day Historical Volatility

    47.43%
    ARDX 10-day historical volatility is 47.43%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $333.62M
    ARDX annual revenue is $333.62 million

    Revenue Analysts Estimate

    $383.76M
    ARDX annual revenue is currently -13.07% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +168.06%
    ARDX annual revenue is up +168.06% year-on-year

    Revenue Sector Percentile

    78.2%
    ARDX annual revenue is higher than 78.2% of companies in Healthcare sector

    EPS

    EPS

    -$0.17
    ARDX annual earnings per share is -$0.17

    EPS Analysts Estimate

    -$0.37
    ARDX annual earnings per share is currently -55.39% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +44.75%
    ARDX annual earnings per share is up +44.75% year-on-year

    EPS Sector Percentile

    75.97%
    ARDX annual earnings per share is higher than 75.97% of companies in Healthcare sector

    Profit

    Gross Profit

    $281.00M
    ARDX annual gross profit is $281.00 million

    Gross Margin

    84.23%
    ARDX annual gross profit margin is 84.23%

    Operating Profit

    -$27.95M
    ARDX annual operating income is -$27.95 million

    Operating Margin

    -8.38%
    ARDX annual operating profit margin is -8.38%

    Net Income

    -$39.14M
    ARDX annual net profit is -$39.14 million

    Net Margin

    -11.73%
    ARDX annual net profit margin is -11.73%

    Expenses

    Total Expenses

    $361.56M
    ARDX annual total expenses is $361.56 million

    Operating Expenses

    $311.01M
    ARDX annual total operating expenses is $311.01 million

    Cost Of Goods Sold

    $52.62M
    ARDX annual cost of goods sold is $52.62 million

    Selling, General & Administrative Expenses

    $258.69M
    ARDX annual SG&A is $258.69 million

    Depreciation & Amortization

    $2.06M
    ARDX annual D&A is $2.06 million

    Interest Expense

    $0.00
    ARDX annual interest expense is $0.00

    Income Tax

    $266.00K
    ARDX annual income tax is $266.00 thousand

    EBIT & EBITDA

    EBIT

    -$18.78M
    ARDX annual earnings before interest & taxes is -$18.78 million

    EBITDA

    -$16.71M
    ARDX annual EBITDA is -$16.71 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $435.75M
    ARDX annual total assets is $435.75 million

    Non Current Assets

    $79.30M
    ARDX annual long term assets is $79.30 million

    Current Assets

    $356.45M
    ARDX annual total current assets is $356.45 million

    Cash and Cash Equivalents

    $64.93M
    ARDX annual cash & cash equivalents is $64.93 million

    Accounts Receivable

    $57.70M
    ARDX annual accounts receivable is $57.70 million

    Inventory

    $21.17M
    ARDX annual inventory is $21.17 million

    Liabilities

    Total Liabilities

    $262.46M
    ARDX annual total liabilities is $262.46 million

    Long Term Liabilities

    $184.63M
    ARDX annual total long term liabilities is $184.63 million

    Current Liabilities

    $77.83M
    ARDX annual current liabilities is $77.83 million

    Accounts Payable

    $16.00M
    ARDX annual accounts payable is $16.00 million

    Debt

    Total Debt

    $153.44M
    ARDX annual total debt is $153.44 million

    Total Debt 1-Year Change

    +174.08%
    ARDX annual total debt is up +174.08% year-on-year

    Long Term Debt

    $151.88M
    ARDX annual long term debt is $151.88 million

    Short Term Debt

    $1.56M
    ARDX annual short term debt is $1.56 million

    Equity & Capital

    Shareholders Equity

    $173.29M
    ARDX annual stockholders equity is $173.29 million

    Book Value

    $173.29M
    ARDX annual book value is $173.29 million

    Retained Earnings

    -$885.34M
    ARDX annual retained earnings is -$885.34 million

    Working Capital

    $278.62M
    ARDX annual working capital is $278.62 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$44.81M
    ARDX annual cash from operations is -$44.81 million

    Cash From Operations 1-Year Change

    +50.06%
    ARDX annual cash from operations is up +50.06% year-on-year

    Cash From Investing

    -$18.32M
    ARDX annual cash from investing is -$18.32 million

    Cash From Investing 1-Year Change

    +86.04%
    ARDX annual cash from investing is up +86.04% year-on-year

    Cash From Financing

    $106.59M
    ARDX annual cash from financing is $106.59 million

    Cash From Financing 1-Year Change

    -27.14%
    ARDX annual cash from financing is down -27.14% year-on-year

    CAPEX

    CAPEX

    $1.01M
    ARDX annual capital expenditures is $1.01 million

    CAPEX 1-Year Change

    +193.9%
    ARDX annual capital expenditures is up +193.9% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$45.82M
    ARDX annual free cash flow is -$45.82 million

    Free Cash Flow 1-Year Change

    +49.12%
    ARDX annual free cash flow is up +49.12% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    84.23%
    ARDX annual gross profit margin is 84.23%

    Operating Margin

    -8.38%
    ARDX annual operating profit margin is -8.38%

    Net Margin

    -11.73%
    ARDX annual net profit margin is -11.73%

    ROA & ROE

    ROA

    -10.67%
    ARDX annual return on assets is -10.67%

    ROE

    -23.01%
    ARDX annual return on equity is -23.01%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ARDX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ARDX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    9.26
    ARDX price to book ratio is 9.26

    PB Ratio Sector Percentile

    87.68%
    ARDX price to book ratio is higher than 87.68% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    3.35
    ARDX price to sales ratio is 3.35

    PS Ratio Sector Percentile

    46.72%
    ARDX price to sales ratio is higher than 46.72% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.26B
    ARDX enterprise value is $1.26 billion

    Enterprise Value Sector Percentile

    75.13%
    ARDX enterprise value is higher than 75.13% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -43.17
    ARDX EV/EBITDA is -43.17

    EV/EBITDA Sector Percentile

    3.51%
    ARDX EV/EBITDA is higher than 3.51% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.58
    ARDX annual current ratio is 4.58

    Quick Ratio

    4.31
    ARDX annual quick ratio is 4.31

    Leverage

    Debt To Equity

    0.87
    ARDX annual debt to equity ratio is 0.87

    Interest Coverage Ratio

    -
    ARDX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    ARDX piotroski f-score is 4

    Altman Z-Score

    1.50
    ARDX altman z-score is 1.50

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 Piper Sandler
    Neutral
    Aug 5, 25 Wedbush
    Outperform
    Aug 5, 25 Raymond James
    Outperform
    May 2, 25 Citigroup
    Buy
    Mar 7, 25 Scotiabank
    Sector Outperform
    Feb 21, 25 Raymond James
    Strong Buy
    Feb 21, 25 HC Wainwright & Co.
    Neutral
    Jan 27, 25 Piper Sandler
    Neutral
    Jan 16, 25 HC Wainwright & Co.
    Neutral
    Jan 2, 25 Jefferies
    Buy

    Institutional Ownership

    Screeners with ARDX included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    • What is the ticker symbol for Ardelyx, Inc.?
    • Does Ardelyx, Inc. pay dividends?
    • What sector is Ardelyx, Inc. in?
    • What industry is Ardelyx, Inc. in?
    • What country is Ardelyx, Inc. based in?
    • When did Ardelyx, Inc. go public?
    • Is Ardelyx, Inc. in the S&P 500?
    • Is Ardelyx, Inc. in the NASDAQ 100?
    • Is Ardelyx, Inc. in the Dow Jones?
    • When was Ardelyx, Inc.'s last earnings report?
    • When does Ardelyx, Inc. report earnings?

    What is the ticker symbol for Ardelyx, Inc.?

    The ticker symbol for Ardelyx, Inc. is NASDAQ:ARDX

    Does Ardelyx, Inc. pay dividends?

    No, Ardelyx, Inc. does not pay dividends

    What sector is Ardelyx, Inc. in?

    Ardelyx, Inc. is in the Healthcare sector

    What industry is Ardelyx, Inc. in?

    Ardelyx, Inc. is in the Biotechnology industry

    What country is Ardelyx, Inc. based in?

    Ardelyx, Inc. is headquartered in United States

    When did Ardelyx, Inc. go public?

    Ardelyx, Inc.'s initial public offering (IPO) was on June 19, 2014

    Is Ardelyx, Inc. in the S&P 500?

    No, Ardelyx, Inc. is not included in the S&P 500 index

    Is Ardelyx, Inc. in the NASDAQ 100?

    No, Ardelyx, Inc. is not included in the NASDAQ 100 index

    Is Ardelyx, Inc. in the Dow Jones?

    No, Ardelyx, Inc. is not included in the Dow Jones index

    When was Ardelyx, Inc.'s last earnings report?

    Ardelyx, Inc.'s most recent earnings report was on August 4, 2025

    When does Ardelyx, Inc. report earnings?

    The next expected earnings date for Ardelyx, Inc. is October 30, 2025
    On this page